European Pharmaceutical Manufacturer, Controlled Media Ltd Company Profile

22:04 EDT 17th March 2018 | BioPortfolio

European Pharmaceutical Manufacturer (EPM) is no ordinary publication. It is a marketing tool written specifically for buyers throughout the European pharmaceutical industry. For Purchasing Managers, EPM will prove an essential reference source that guarantees their purchase tenders go to all the appropriate suppliers. For busy R&D and production managers, EPM will fulfil their duty of keeping up to speed on new processing technologies without taking all day!


Pluto House, High Street
CH3 9PX,
United Kingdom


Phone: 44 (0)1829 77 00 37
Fax: 44 (0)1829 77 00 47

News Articles [2406 Associated News Articles listed on BioPortfolio]

Strategic partnership formed to produce US DEA controlled substances

Producer of controlled substances for the pharma industry, Noramco, has entered into a strategic partnership with active pharmaceutical ingredient (API) manufacturer, AMPAC Fine Chemicals (AFC), to pr...

Mass media linked to childhood obesity

(Wiley) A task force from the European Academy of Paediatrics and the European ChildhoodObesity Group has found evidence of a strong link between obesity levels across European countries and childhood...

Social Media in the Pharmaceutical Industry #pharmasocialmedia

22 - 23 January 2018, London, UK. Social media is the perfect channel for pharmaceutical companies to educate, market, listen and connect with customers, patients and physicians. How the pharmaceutica...

Preparation of pre-approved content for use in pharma social media channels

In this article, the fourth in a series of ‘how-to’ guides for the pharmaceutical industry, Paul Grant looks at pre-approving content for use in a social media engagement strategy. Previously we l...

EMA regulatory guidance update to prepare for Brexit

In preparation for the UK’s withdrawal from the European Union (EU), set to take place on 29 March 2019, the European Medicines Agency (EMA) and the European Commission have issued regulatory guidan...

Treatment for melanoma in adolescents approved by European Commission

Global pharmaceutical company Bristol-Myers Squibb announced that cancer drug Yervoy (ipilimumab) has been approved by the European Commission for the...Read More... The post Treatment for melanoma in...

European Commission authorises ADCETRIS for T-cell lymphoma

Seattle Genetics and Takeda Pharmaceutical have received extended marketing authorisation from the European Commission (EC) for ADCETRIS (brentuximab vedotin) to...Read More... The post European Commi...

ABcann Global Executive Team Highlights Recreational and Pharmaceutical Focus -- CFN Media

Seattle, Washington--(Newsfile Corp. - December 4, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an art...

PubMed Articles [3776 Associated PubMed Articles listed on BioPortfolio]

Editorial Special Supplement of the European Journal of Pharmaceutical Sciences on the occasion of the retirement of Professor Meindert Danhof as Professor of Pharmacology at Leiden University.

Process and scaling parameters for wet media milling in early phase drug development: A knowledge based approach.

Wet media milling is a well-established unit operation for the manufacturing of suspension formulations during early phase pharmaceutical development. However, knowledge about the kinetics of particle...

Zwitterionic cocrystal of diclofenac and l-proline: Structure determination, solubility, kinetics of cocrystallization, and stability study.

Special Issue "SimInhale".

The effect of 2-hydroxypropyl-β-cyclodextrin on the intestinal permeation through mucus.

In addition to its important role in preventing the interaction of toxic agents with the intestinal lining, the intestinal mucus layer can impede the permeation of drugs. The purpose of this study was...

Clinical Trials [2100 Associated Clinical Trials listed on BioPortfolio]

Pharmaceutical Care for Diabetes Type 2 Patients: a Randomised Controlled Trial

The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for diabetes type 2 patients. Patients will be randomly allocated to th...

Project Amaze - Social Media Alcohol Intervention

Social media provides frequent interaction with online social networks, increasing exposure to peer influences, which could affect alcohol use in negative or positive ways. The proposed st...

Bioequivalence Study of Daclatasvir From Daktavira 60 mg Film Coated Tablets ( European Egyptian Pharmaceutical Industries, Egypt) Versus Daklinza 60 mg Tablets (Bristol-Myers Squibb Pharma, UK)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Daclatasvir from Daktavira 60 mg film coated tablets ( European Egyptian Ph...

Pharmaceutical Care Service in Diabetes

The purpose of this study is to examine the effectiveness of pharmaceutical care service in the management of poorly controlled type 2 diabetes mellitus.

Small Media Interventions to Increase Colorectal Cancer Screening Among Chinese Americans

There have been few studies of small media interventions to promote colorectal cancer screening among Chinese Americans. Based on the results of strong preliminary studies on the promotion...

Companies [3491 Associated Companies listed on BioPortfolio]

European Pharmaceutical Manufacturer, Controlled Media Ltd

European Pharmaceutical Manufacturer (EPM) is no ordinary publication. It is a marketing tool written specifically for buyers throughout the European pharmaceutical industry. For Purchasing Managers, ...

EFPIA (The European Federation of Pharmaceutical Industries and Associations)

EFPIA (The European Federation of Pharmaceutical Industries and Associations) represents the research-based pharmaceutical industry operating in Europe.Through its direct membership of 28 national pha...

Phaermaceutical Technology

Pharmaceutical Technology Europe (PTE) magazine is the market-leading publication for European professionals actively involved in pharmaceutical/biopharmaceutical development, manufacturing and QA/QC....

heipha Dr. Müller GmbH

heipha Dr. Müller GmbH is a leading manufacturer of high quality culture media for microbial diagnostics, environmental monitoring and sterility testing. We offer more than 600 different products use...

Key International

Key International, Inc., a New Jersey based manufacturer founded in 1968, provides products and services to the Pharmaceutical, Food, Cosmetic and Chemical industries. The Company's objective is to be...

More Information about "European Pharmaceutical Manufacturer, Controlled Media Ltd" on BioPortfolio

We have published hundreds of European Pharmaceutical Manufacturer, Controlled Media Ltd news stories on BioPortfolio along with dozens of European Pharmaceutical Manufacturer, Controlled Media Ltd Clinical Trials and PubMed Articles about European Pharmaceutical Manufacturer, Controlled Media Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Pharmaceutical Manufacturer, Controlled Media Ltd Companies in our database. You can also find out about relevant European Pharmaceutical Manufacturer, Controlled Media Ltd Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record